DK0667898T3 - Anvendelser af TAU/neurofilamentproteinkinasen PK40 - Google Patents
Anvendelser af TAU/neurofilamentproteinkinasen PK40Info
- Publication number
- DK0667898T3 DK0667898T3 DK92915162T DK92915162T DK0667898T3 DK 0667898 T3 DK0667898 T3 DK 0667898T3 DK 92915162 T DK92915162 T DK 92915162T DK 92915162 T DK92915162 T DK 92915162T DK 0667898 T3 DK0667898 T3 DK 0667898T3
- Authority
- DK
- Denmark
- Prior art keywords
- kinases
- tau
- applications
- protein kinase
- neurofilament protein
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10341—Use of virus, viral particle or viral elements as a vector
- C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10341—Use of virus, viral particle or viral elements as a vector
- C12N2710/10345—Special targeting system for viral vectors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Biophysics (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Immunology (AREA)
- Hospice & Palliative Care (AREA)
- Virology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Enzymes And Modification Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US74288091A | 1991-08-09 | 1991-08-09 | |
| PCT/US1992/005825 WO1993003148A2 (en) | 1991-08-09 | 1992-07-10 | Tau/neurofilament protein kinases pk40 and pk36 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0667898T3 true DK0667898T3 (da) | 2002-02-04 |
Family
ID=24986618
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK00104460T DK1026237T3 (da) | 1991-08-09 | 1992-07-10 | Anvendelse af en inhibitor af Tau/neurofilament-proteinkinase PK40 |
| DK92915162T DK0667898T3 (da) | 1991-08-09 | 1992-07-10 | Anvendelser af TAU/neurofilamentproteinkinasen PK40 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK00104460T DK1026237T3 (da) | 1991-08-09 | 1992-07-10 | Anvendelse af en inhibitor af Tau/neurofilament-proteinkinase PK40 |
Country Status (9)
| Country | Link |
|---|---|
| EP (2) | EP0667898B1 (da) |
| JP (1) | JPH06510427A (da) |
| AT (2) | ATE262584T1 (da) |
| AU (1) | AU675410B2 (da) |
| CA (1) | CA2115151C (da) |
| DE (2) | DE69233330T2 (da) |
| DK (2) | DK1026237T3 (da) |
| ES (2) | ES2165358T3 (da) |
| WO (1) | WO1993003148A2 (da) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69233767D1 (de) * | 1991-12-06 | 2009-09-17 | Max Planck Gesellschaft | Verwendung von Protein-Kinasen zur Diagnose und Behandlung der Alzheimer-Krankheit |
| US7408027B1 (en) | 1991-12-06 | 2008-08-05 | Max-Planck-Gesellschaft Zur Forderung Der Wissenchaften | Tools for the diagnosis and treatment of Alzheimer's disease |
| JPH07506969A (ja) * | 1992-05-11 | 1995-08-03 | ルードヴィッヒ・インスティテュート・フォア・キャンサー・リサーチ | レセプタ型チロシンキナーゼ類似の分子 |
| US6013646A (en) * | 1998-07-02 | 2000-01-11 | Bayer Corporation | Indolocarbazole derivatives useful for the treatment of neurodegenerative diseases and cancer |
| CN1461366A (zh) * | 2000-07-07 | 2003-12-10 | 美利肯公司 | 具有耐久拒水和易去污性的纺织基材及其制法 |
| JP5186212B2 (ja) | 2004-09-23 | 2013-04-17 | ウィスタ ラボラトリーズ リミテッド | メチルチオニニウム塩化物（ｍｔｃ）などのジアミノフェノチアジニウム化合物を化学合成および精製する方法 |
| US9540434B2 (en) * | 2011-10-07 | 2017-01-10 | Ac Immune S.A. | Phosphospecific antibodies recognising tau |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0491792A4 (en) * | 1989-09-15 | 1992-12-02 | Gensia Pharmaceuticals, Inc. | Methods of treating neurodegenerative conditions |
| HUT61567A (en) * | 1990-12-07 | 1993-01-28 | Sandoz Ag | Process for producing new pharmaceutical compositions comprising 2'-o-alkyladenosine derivatives and for producing 6-cyclohexyl-2'-o-methyladenosinehydrate |
| WO1993003177A1 (en) * | 1991-08-09 | 1993-02-18 | Massachusetts Institute Of Technology | Novel tau/neurofilament protein kinases |
| EP0544942A1 (en) * | 1991-12-06 | 1993-06-09 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Novel tools for the diagnosis and treatment of Alzheimer disease |
-
1992
- 1992-07-10 JP JP5503575A patent/JPH06510427A/ja active Pending
- 1992-07-10 DE DE69233330T patent/DE69233330T2/de not_active Expired - Fee Related
- 1992-07-10 DE DE69232121T patent/DE69232121T2/de not_active Expired - Fee Related
- 1992-07-10 WO PCT/US1992/005825 patent/WO1993003148A2/en active IP Right Grant
- 1992-07-10 AU AU23240/92A patent/AU675410B2/en not_active Ceased
- 1992-07-10 CA CA002115151A patent/CA2115151C/en not_active Expired - Fee Related
- 1992-07-10 AT AT00104460T patent/ATE262584T1/de not_active IP Right Cessation
- 1992-07-10 ES ES92915162T patent/ES2165358T3/es not_active Expired - Lifetime
- 1992-07-10 ES ES00104460T patent/ES2216745T3/es not_active Expired - Lifetime
- 1992-07-10 EP EP92915162A patent/EP0667898B1/en not_active Expired - Lifetime
- 1992-07-10 DK DK00104460T patent/DK1026237T3/da active
- 1992-07-10 DK DK92915162T patent/DK0667898T3/da active
- 1992-07-10 AT AT92915162T patent/ATE206755T1/de not_active IP Right Cessation
- 1992-07-10 EP EP00104460A patent/EP1026237B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| WO1993003148A2 (en) | 1993-02-18 |
| DE69232121D1 (de) | 2001-11-15 |
| DE69233330D1 (de) | 2004-04-29 |
| AU675410B2 (en) | 1997-02-06 |
| AU2324092A (en) | 1993-03-02 |
| EP0667898B1 (en) | 2001-10-10 |
| EP1026237A3 (en) | 2001-03-28 |
| ES2216745T3 (es) | 2004-11-01 |
| ES2165358T3 (es) | 2002-03-16 |
| ATE262584T1 (de) | 2004-04-15 |
| CA2115151C (en) | 2005-05-17 |
| DE69233330T2 (de) | 2005-03-10 |
| ATE206755T1 (de) | 2001-10-15 |
| DE69232121T2 (de) | 2002-06-20 |
| EP1026237B1 (en) | 2004-03-24 |
| WO1993003148A3 (en) | 1993-04-01 |
| EP1026237A2 (en) | 2000-08-09 |
| JPH06510427A (ja) | 1994-11-24 |
| EP0667898A1 (en) | 1995-08-23 |
| CA2115151A1 (en) | 1993-02-18 |
| DK1026237T3 (da) | 2004-07-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE299145T1 (de) | Neues multimerisierendes reagenz | |
| DE69731285D1 (de) | Langwellig fluorezierende proteine | |
| EP1903112A3 (en) | Activin receptors-like kinase(alk), belonging to the TGF receptor family and/or to the BMP receptor family | |
| DK0624595T3 (da) | Nor-galdesyrederivater, fremgangsmåde til deres fremstilling og anvendelse af disse forbindelser som lægemidler | |
| DE59310337D1 (de) | 2,4-Dioxo-imidazolidin-Derivate | |
| DE69412828D1 (de) | Zusammensetzung zur benetzung von kontaktlinsen | |
| FI952198A0 (fi) | Stabiili kiteinen (6S)- ja (6R)-tetrahydrofoolihappo | |
| FI942457A (fi) | Substituoitujen piperidiinien valmistus | |
| DK0667898T3 (da) | Anvendelser af TAU/neurofilamentproteinkinasen PK40 | |
| DK0638068T3 (da) | Fremgangsmåde til fremstilling af (S)-3-amino-1-substitueret-pyrrolidiner | |
| ITTV930109A1 (it) | Struttura di dispositivo di aggancio, particolarmente per lenti di occhiali | |
| NO930205L (no) | Benzimidazoler, legemidler inneholdende disse, og fremgangsmaate for deres fremstilling | |
| AR022150A1 (es) | Acidos nucleicos derivados de monocitos y composiciones y metodos relacionados | |
| DK0528601T3 (da) | Fremgangsmåde til forbedring af pigmenters lagerstabilitet. | |
| DK0519512T3 (da) | Mikrobiologisk fremgangsmåde til fremstilling af 5-hydroxypyrazincarboxylsyre | |
| DK192890A (da) | 24r-scumnol, fremgangsmaade til fremstilling heraf samt anvendelse af samme | |
| DE3851979D1 (de) | Substituierte Vinylcephalosporine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel. | |
| DE59000772D1 (de) | Seitenstaendige carbazolyl-gruppen enthaltende methacrylat-(co)polymerisate und elektrophotographische aufzeichnungselemente, enthaltend dieselben. | |
| DK159139C (da) | Fremgangsmaade til fremstilling af flade emner, saasom luvforsynede maatter | |
| DK133793D0 (da) | Fremgangsmaade til dehydrogenering af carbonhydrider | |
| NO305556B1 (no) | Tiokarbamoylforbindelser og anvendelse derav samt middel for beskyttelse av tekniske materialer | |
| DK0582977T3 (da) | Fremgangsmåde til fremstilling af 1,3-dialkyl-5-hydroxyoxindoler og etherderivater deraf | |
| ATE38670T1 (de) | Durch stickstoffhaltige heterocyclische ringe substituierte triazolo(4,3-c>pyrimidine und triazolo(1,5-c>pyrimidine. | |
| GR1001386B (el) | Ετεροκυκλικές ενώσεις. | |
| ITMI931034A1 (it) | Processo per la preparazione di proteine inibenti i ribosomi |